Inventor

MCKENNA JOSEPH

GB8 patents

⚠️ This page may combine multiple inventors who share the name “MCKENNA JOSEPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SHIEH WEN-CHUNG

2 patents

US8946416B2Feb 3, 2015

Process for the synthesis of 5-(methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzeneamine

SHIEH WEN-CHUNG6 citations80

US8124763B2Feb 28, 2012

Process for the synthesis of 5-(methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzeneamine

SHIEH WEN-CHUNG6 citations80

AHMED MAHBUB

2 patents

US9359381B2Jun 7, 2016

Tricyclic compounds for inhibiting the CFTR channel

AHMED MAHBUB0 citations26

US9303035B2Apr 5, 2016

Substituted pyrazino[1′,2′:1,2]pyrrolo[3,4-d]pyrimidines, pyrimido[4′,5′:3,4]pyrrolo[2,1-c][1,4]oxazines and pyrimido[4′,5′:3,4]pyrrolo[1,2-d][1,4]oxazepines for inhibiting the CFTR channel

AHMED MAHBUB0 citations25

MCKENNA JOSEPH

1 patent

USD656392SMar 27, 2012

Panel fastener

MCKENNA JOSEPH22 citations86

(unassigned)

1 patent

US6694616B1Feb 24, 2004

Method of forming T-connectors

BERGHAUSEN JOERG

1 patent

US9067896B2Jun 30, 2015

Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl) -phenylamino]-pyrimidin-4-yl}-1-methyl-urea and salts thereof

BERGHAUSEN JOERG11 citations79

NOVARTIS AG

1 patent

US12083101B2Sep 10, 2024

Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors

NOVARTIS AG0 citations46